PURE Bioscience, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PURE Bioscience, Inc. stock issued during period, value, new issues for the quarter ending 2026-04-30 was $1.00M.
- PURE Bioscience, Inc. stock issued during period, value, new issues for the quarter ending 2020-07-31 was $0.00, a 100.00% decline year-over-year.
- PURE Bioscience, Inc. stock issued during period, value, new issues for the quarter ending 2020-04-30 was $2.00M.
- PURE Bioscience, Inc. stock issued during period, value, new issues for the quarter ending 2020-01-31 was $0.00.
- PURE Bioscience, Inc. stock issued during period, value, new issues for fiscal 2022 was $3.50M.
- PURE Bioscience, Inc. stock issued during period, value, new issues for fiscal 2020 was $2.83M, a 27.82% increase from fiscal 2019.
- PURE Bioscience, Inc. stock issued during period, value, new issues for fiscal 2019 was $2.21M.
- PURE Bioscience, Inc. stock issued during period, value, new issues for fiscal 2013 was $4.23M, a 345.42% increase from fiscal 2012.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-04-30 | $1.00M 10-Q · filed 2026-06-15 | |
| 2022-07-31 | $3.50M 10-K · filed 2023-10-30 | |
| 2020-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-28 | $2.83M 10-K · filed 2021-10-28 |
| 2020-04-30 | $2.00M 10-Q · filed 2021-06-15 | $3.55M derived: sum of 4 quarters · filed 2021-06-15 |
| 2020-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-03-15 | $1.55M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-10-31 | $830.00K 10-Q · filed 2020-12-15 | |
| 2019-07-31 | $717.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-08 | $2.21M 10-K · filed 2020-10-08 |
| 2019-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-11 | |
| 2013-07-31 | $4.23M 10-K · filed 2014-10-28 | |
| 2012-07-31 | $949.00K 10-K · filed 2013-10-24 | |
| 2011-07-31 | $3.06M 10-K · filed 2012-10-29 |